Edwards Lifesciences Corp. (EW)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Edwards Lifesciences Corp. (EW)
Go deeper and ask any question about EW
Company Performance
Current Price
as of Sep 18, 2024$67.53
P/E Ratio
27.79
Market Cap
$40.68B
Description
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Metrics
Overview
- HQIrvine, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerEW
- Price$67.53+0.45%
Trading Information
- Market Cap$40.68B
- Float98.28%
- Average Daily Volume (1m)6,459,940
- Average Daily Volume (3m)6,149,044
- EPS$2.44
Company
- Revenue$6.00B
- Rev Growth (1yr)-9.43%
- Net Income$367.70M
- Gross Margin78.51%
- EBITDA Margin29.17%
- EBITDA$404.30M
- EV$54.59B
- EV/Revenue9.10
- P/E27.79
- P/S6.80
Documents
SEC Filings
Earnings Calls
Factset Street Account
StreetAccount Metrics Recap - Edwards Lifesciences Q3 Earnings ($68.34, 0.00) (2023-10-25T20:22:05Z)
Factset